NCT00440258View on ClinicalTrials.gov

Cabergoline Reduces OHSS

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

July 31, 2006

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

DRUG

Cabergoline

PROCEDURE

MR

PROCEDURE

Ultrasound

PROCEDURE

Blood Analysis

All Listed Sponsors

lead

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER

NCT00440258 - Cabergoline Reduces OHSS | Biotech Hunter | Biotech Hunter